Replies to post #429448 on NorthWest Biotherapeutics Inc (NWBO)

[X Master]

Merck knows better than anyone the value of extending their patent on Keytruda. Merck knows the results of their clinical trial with DCVax. Merck needs DCVax to continue their number product and Linda knows it. They will cut a deal. All IMO.